Makoto Kammori
Overview
Explore the profile of Makoto Kammori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
511
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kammori M, Kanazawa S, Ogata H, Kanda N, Nagashima T, Kammori M, et al.
Front Surg
. 2022 Jun;
9:864255.
PMID: 35647017
An ectopic parathyroid adenoma (EPA) is a rare entity. The aim of this study was to report our experience in the preoperative localization and surgical management of EPAs. This was...
2.
Kanazawa S, Kammori M
J Nippon Med Sch
. 2019 Mar;
86(1):38-42.
PMID: 30918155
We present a rare case of a patient with anaplastic thyroid carcinoma (ATC) who survived for 87 months after surgery. The patient was a 71-year-old man who presented with a...
3.
Onoda N, Sugino K, Higashiyama T, Kammori M, Toda K, Ito K, et al.
Thyroid
. 2016 Aug;
26(9):1293-9.
PMID: 27484330
Background: Anaplastic thyroid cancer (ATC) is a rare and extremely aggressive malignancy, with a median survival of less than 6 months due to rapid progression and resistance to multimodal therapies....
4.
Hirokawa M, Sugitani I, Kakudo K, Sakamoto A, Higashiyama T, Sugino K, et al.
Endocr J
. 2016 Feb;
63(5):441-7.
PMID: 26842589
The aim of this study was to clarify the histopathological features of anaplastic thyroid carcinoma in patients who achieved long-term survival. We reviewed 88 anaplastic thyroid carcinoma cases in which...
5.
Kammori M, Fukumori T, Sugishita Y, Hoshi M, Shimizu K, Yamada T
Endocr J
. 2015 Oct;
62(12):1067-75.
PMID: 26424174
In general, juvenile differentiated thyroid carcinoma (DTC) demonstrate indolent characteristics and favorable prognosis are observed in comparison with many other carcinomas. However, recurrence is frequent, necessitating additional treatment, including radioactive...
6.
Onoda N, Sugitani I, Higashiyama T, Hara H, Ito K, Kammori M, et al.
BMC Cancer
. 2015 Jun;
15:475.
PMID: 26091846
Background: Anaplastic thyroid cancer (ATC) is one of the most aggressive malignancies in humans, often demonstrating resistance to multimodal therapeutic approaches. The median survival of ATC patients after initial diagnosis...
7.
Kammori M, Sugishita Y, Okamoto T, Kobayashi M, Yamazaki K, Yamada E, et al.
Oncol Rep
. 2015 Jun;
34(2):627-32.
PMID: 26080929
Telomeres are involved in the maintenance of genomic stability. Telomere alteration has been observed in most human cancer types, and is known to be a feature of malignancy. The aim...
8.
Sugishita Y, Kammori M, Yamada O, Yamazaki K, Ito K, Fukumori T, et al.
Ann Surg Oncol
. 2014 Feb;
21(7):2318-25.
PMID: 24562933
Background: The most difficult thyroid tumors to diagnose by histology are follicular carcinomas (FTCs) and Hürthle cell carcinomas (HCCs). Telomere alteration and human telomerase reverse transcriptase (hTERT) expression have been...
9.
Ishido Y, Yamazaki K, Kammori M, Sugishita Y, Luo Y, Yamada E, et al.
J Clin Endocrinol Metab
. 2014 Jan;
99(4):E694-702.
PMID: 24433000
Context: It was shown in the rat thyroid that thyroglobulin (Tg) stored in the follicular lumen is a potent regulator of thyroid-specific gene expression to maintain the function of individual...
10.
Kammori M, Fukumori T, Sugishita Y, Hoshi M, Yamada T
Endocr J
. 2013 Sep;
61(1):1-12.
PMID: 24067543
It is well-known that differentiated thyroid carcinoma (DTC) has a generally indolent character and shows a favorable prognosis in comparison with many other carcinomas. The therapeutic strategy for patients with...